HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCENTAGE-B

77.450

-1.900-2.39%

Volume:6.08M

Turnover:470.60M

Market Cap:26.97B

PE:-52.71

High:81.300

Open:79.950

Low:75.000

Close:79.350

Loading ...

Overview Company News Filings

Ascentage Pharma Announces New Compensation Plan Under 2021 and 2022 RSU Schemes to Reward and Retain Key Talent

Ascentage Pharma Unveils Promising Results from Olverembatinib and APG-5918 Clinical Studies at 2025 EHA Congress

Ascentage Pharma Announces 13 Studies Featuring Olverembatinib and Lisaftoclax at 2025 European Hematology Association Congress

Ascentage Pharma Group International Announces Regulatory Review for Lisaftoclax in China Following New Drug Application Submission

Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at Asco 2025

THOMSON REUTERS

Ascentage Pharma Group International Conducted Annual General Meeting

Ascentage Pharma Presents Results of Five Preclinical Studies for Anti-Cancer Drugs

MT Newswires Live

Ascentage Pharma Trustee Buys HK$1.8 Million Shares

MT Newswires Live

SPDB International HK Starts Ascentage Pharma Group International at Buy with HK$57 Price Target

MT Newswires Live

Ascentage Pharma Group International Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

Ascentage Pharma Narrows Loss in 2024

MT Newswires Live

BRIEF-Ascentage Pharma Group International Says Revenue In 2024 Increased 342% Year-Over-Year

BRIEF-Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results And Business Updates

Ascentage Pharma Group International - Revenue in 2024 Increased 342% Year-Over-Year to RMB980.7 Mln

THOMSON REUTERS

Press Release: Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates

China Designates Ascentage's Olverembatinib Cancer Therapy as Breakthrough Therapy

MT Newswires Live

BRIEF-Ascentage Pharma Group International Says Olverembatinib Given Breakthrough Therapy Designation

Ascentage Pharma Group International - Olverembatinib Given Breakthrough Therapy Designation by Center for Drug Evaluation of China Nmpa

THOMSON REUTERS

BRIEF-Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Olverembatinib Granted Breakthrough Therapy Designation for Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (All)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06855/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06855","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06855\",,,,,undefined,":{"symbol":"06855","market":"HK","secType":"STK","nameCN":"ASCENTAGE-B","latestPrice":77.45,"timestamp":1751011733031,"preClose":79.35,"halted":0,"volume":6079642,"delay":0,"floatShares":348266581,"shares":348266581,"eps":-1.4692509610729085,"marketStatus":"Market Closed","change":-1.9,"latestTime":"06-27 16:08:53","open":79.95,"high":81.3,"low":75,"amount":470599821,"amplitude":0.079395,"askPrice":77.45,"askSize":5700,"bidPrice":77.3,"bidSize":2600,"shortable":3,"etf":0,"ttmEps":-1.4692509610729085,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751247000000},"marketStatusCode":7,"adr":0,"listingDate":1572192000000,"exchange":"SEHK","adjPreClose":79.35,"openAndCloseTimeList":[[1750987800000,1750996800000],[1751000400000,1751011200000]],"volumeRatio":1.1735508226434386,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06855\",,,,,undefined,":{"symbol":"06855","floatShares":348266581,"roa":"-9.25%","roe":"-235.32%","lyrEps":-1.469251,"volumeRatio":1.1735508226434386,"shares":348266581,"dividePrice":0,"high":81.3,"amplitude":0.079395,"preClose":79.35,"low":75,"week52Low":25.25,"pbRate":"93.27","psRate":"25.13","week52High":81.3,"institutionHeld":0,"latestPrice":77.45,"committee":-0.373494,"eps":-1.4692509610729085,"divideRate":0,"volume":6079642,"delay":0,"ttmEps":-1.4692509610729085,"open":79.95,"prevYearClose":45.45,"prevWeekClose":72.25,"prevMonthClose":50.15,"prevQuarterClose":42.35,"fiveDayClose":72.25,"twentyDayClose":50.15,"sixtyDayClose":43},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06855\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546466537","title":"Ascentage Pharma Announces New Compensation Plan Under 2021 and 2022 RSU Schemes to Reward and Retain Key Talent","url":"https://stock-news.laohu8.com/highlight/detail?id=2546466537","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546466537?lang=en_us&edition=fundamental","pubTime":"2025-06-27 20:55","pubTimestamp":1751028945,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International has announced further grants under its 2021 and 2022 RSU Schemes. The grants include awards for specific 2022 Selected Persons, aimed at rewarding their contributions to the company's growth. Notably, the grant of 2022 Awards to Dr. Zhai has received approval from independent non-executive directors, ensuring compliance with relevant regulations. The vesting of the 2021 Awards is contingent upon the recipients achieving satisfactory annual performance review scores. Additionally, a clawback mechanism is in place, allowing the company to rescind unvested RSUs under certain conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content us","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL7wxQt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2543126506","title":"Ascentage Pharma Unveils Promising Results from Olverembatinib and APG-5918 Clinical Studies at 2025 EHA Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2543126506","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543126506?lang=en_us&edition=fundamental","pubTime":"2025-06-16 07:59","pubTimestamp":1750031989,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International has announced the release of results from multiple clinical studies at the 2025 European Hematology Association  Hybrid Congress. The company presented findings from 13 studies focusing on its core assets, including the novel drug olverembatinib  and the investigational EED inhibitor APG-5918. Notably, olverembatinib demonstrated significant therapeutic potential and clinical benefits in treating Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia , with high complete remission and molecular response rates. Additionally, a preclinical study on APG-5918 showed its potent antitumor activity in T-cell lymphoma, supporting further clinical development. The results were featured in various formats, including poster presentations at the congress.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250615:nNDL5mLPpb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2542185463","title":"Ascentage Pharma Announces 13 Studies Featuring Olverembatinib and Lisaftoclax at 2025 European Hematology Association Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2542185463","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542185463?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:02","pubTimestamp":1749549734,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Announces 13 Studies Featuring Olverembatinib and Lisaftoclax at 2025 European Hematology Association Congress. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL64lMvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2537768329","title":"Ascentage Pharma Group International Announces Regulatory Review for Lisaftoclax in China Following New Drug Application Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2537768329","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537768329?lang=en_us&edition=fundamental","pubTime":"2025-05-23 08:16","pubTimestamp":1747959375,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International Announces Regulatory Review for Lisaftoclax in China Following New Drug Application Submission. Ascentage Pharma Group International has recently announced the submission of a new drug application for lisaftoclax in China, marking a significant milestone in the program's progress. This novel Bcl-2 inhibitor has demonstrated antitumor activity in both previously untreated patients and those treated with venetoclax, addressing critical treatment gaps in difficult-to-treat myeloid malignancies. If approved, lisaftoclax would be the second Bcl-2 inhibitor to receive approval globally. This regulatory submission underscores Ascentage Pharma's commitment to developing innovative therapies for patients with limited treatment options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL7JRX7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","NDAQ","BK1161","06855","BK4112","BK4588","BK4585","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD"],"gpt_icon":0},{"id":"2537997683","title":"Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at Asco 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537997683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537997683?lang=en_us&edition=fundamental","pubTime":"2025-05-23 08:15","pubTimestamp":1747959352,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nTUA1SY1D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2536689127","title":"Ascentage Pharma Group International Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2536689127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536689127?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:03","pubTimestamp":1747656232,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International held its Annual General Meeting on May 19, 2025. All proposed resolutions were approved by the shareholders, including the Service Provider Sublimit on the total number of shares that may be issued under the Share Schemes of the Company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL6cx5b5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2531274471","title":"Ascentage Pharma Presents Results of Five Preclinical Studies for Anti-Cancer Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531274471","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531274471?lang=en_us&edition=fundamental","pubTime":"2025-04-29 16:46","pubTimestamp":1745916373,"startTime":"0","endTime":"0","summary":"Ascentage Pharma  presented the results of five preclinical studies at the meeting of the American Association for Cancer Research in Chicago, according to a Monday filing with the Hong Kong bourse.The presentations, in poster form, are for its olverembatinib and lisaftoclax drugs for acute myeloid leukemia, as well as APG-5918 for prostate cancer, APG-2449 for small-cell lung cancer, and AS03157 for apoptosis protein inhibition or cell death prevention, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2526333472","title":"Ascentage Pharma Trustee Buys HK$1.8 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2526333472","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526333472?lang=en_us&edition=fundamental","pubTime":"2025-04-09 16:19","pubTimestamp":1744186755,"startTime":"0","endTime":"0","summary":"Ascentage Pharma's (HKG:6855) trustee purchased 50,000 shares at an average of HK$35.20 apiece under its restricted share unit scheme, according to a Tuesday filing with the Hong Kong bourse.The total consideration for the shares hit about HK$1.8 million, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2524236075","title":"SPDB International HK Starts Ascentage Pharma Group International at Buy with HK$57 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2524236075","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524236075?lang=en_us&edition=fundamental","pubTime":"2025-04-03 17:56","pubTimestamp":1743674166,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International (HKG:6855) has an average rating of buy and mean price target of HK$53.11, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and econo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06855"],"gpt_icon":0},{"id":"2523108654","title":"Ascentage Pharma Group International Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2523108654","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523108654?lang=en_us&edition=fundamental","pubTime":"2025-03-29 07:32","pubTimestamp":1743204776,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International ( HKG:6855 ) Full Year 2024 Results Key Financial Results Revenue: CN¥980.7m (up...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6855/ascentage-pharma-group-international-shares/news/ascentage-pharma-group-international-full-year-2024-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06855"],"gpt_icon":0},{"id":"2522716675","title":"Ascentage Pharma Narrows Loss in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2522716675","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522716675?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:55","pubTimestamp":1743166500,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International  narrowed its attributable loss in 2024 to 405.4 million yuan from 925.6 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse said.Loss per share stood at 1.34 yuan, narrower than 3.28 yuan in 2023.The drugmaker's revenue for the year increased by 342% to 980.7 million yuan from 222 million yuan a year prior.The higher revenue was partly attributable to intellectual property income from Takeda Pharmaceuticals International and the strong sales growth of olverembatinib.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2522308552","title":"BRIEF-Ascentage Pharma Group International Says Revenue In 2024 Increased 342% Year-Over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2522308552","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522308552?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:42","pubTimestamp":1743079350,"startTime":"0","endTime":"0","summary":"BRIEF-Ascentage Pharma Group International Says Revenue In 2024 Increased 342% Year-Over-YearMarch 27  - Ascentage Pharma Group International 6855.HK:REVENUE IN 2024 INCREASED 342% YEAR-OVER-YEAR TO RMB980.7 MILLIONFY LOSS OF GROUP RMB405.7 MILLIONFurther company coverage: 6855.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855"],"gpt_icon":0},{"id":"2522371681","title":"BRIEF-Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results And Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522371681","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522371681?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:39","pubTimestamp":1743075579,"startTime":"0","endTime":"0","summary":"BRIEF-Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results And Business UpdatesMarch 27 (Reuters) - Ascentage Pharma Group International 6855.HK:ASCENTAGE PHARMA REPORTS FULL YEAR 2024 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA7ZXNRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2522937550","title":"Ascentage Pharma Group International - Revenue in 2024 Increased 342% Year-Over-Year to RMB980.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522937550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522937550?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073258,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2522755023","title":"Press Release: Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522755023","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522755023?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"-- Revenue in 2024 increased 342% year-over-year to US$134.3 million. , attributable in part to Takeda's option payment and. -- Sales of olverembatinib in China in 2024 increased 52% year-over-year to. -- Completion of U.S. initial public offering on Nasdaq in January 2025,27, 2025 and Chinese  investor event with simultaneous. Dr. Dajun Yang, Chairman and Chief Executive Officer of Ascentage Pharma, said, \"As we reflect on our achievements in 2024, I am delighted to report that Ascentage Pharma has made remarkable strides in advancing our mission to deliver innovative therapies to patients worldwide. The commercialization of olverembatinib in China has gained significant traction in 2024 and is poised for growth in 2025 as all approved indications of olverembatinib are now covered under China's National Reimbursement Drug List , markedly enhancing affordability and accessibility for patients across China.\". \"Our clinical development programs also achieved significant progress over the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","06855","CDE","BK4017","BK6514","BK6008","DTP","BK4203","HR","5BI.SI","BK4588","BK1574","BK4500","AAPG","ALK","BK4008","BK1161","BK4225","BK4139"],"gpt_icon":0},{"id":"2517183402","title":"China Designates Ascentage's Olverembatinib Cancer Therapy as Breakthrough Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517183402","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517183402?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:29","pubTimestamp":1741242590,"startTime":"0","endTime":"0","summary":"The Center for Drug Evaluation of China's National Medical Products Administration granted Ascentage Pharma Group International's  olverembatinib its third breakthrough therapy designation, a Thursday bourse filing said.The designation is for the drug's combination with low-intensity chemotherapy for treating newly-diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, a type of blood cancer caused by a genetic mutation in certain chromosomes.The drug has been granted breakthrough therapy designation twice before, once in March 2021 for the treatment of patients with chronic-phase chronic myeloid leukemia and then in June 2023 for patients with succinate dehydrogenase-deficient gastrointestinal stromal tumors.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2517716729","title":"BRIEF-Ascentage Pharma Group International Says Olverembatinib Given Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716729","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517716729?lang=en_us&edition=fundamental","pubTime":"2025-03-06 08:52","pubTimestamp":1741222374,"startTime":"0","endTime":"0","summary":"BRIEF-Ascentage Pharma Group International Says Olverembatinib Given Breakthrough Therapy Designation March 6 (Reuters) - Ascentage Pharma Group International 6855.HK:OLVEREMBATINIB GIVEN BREAKTHROUGH","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PO0WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2517975834","title":"Ascentage Pharma Group International - Olverembatinib Given Breakthrough Therapy Designation by Center for Drug Evaluation of China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2517975834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517975834?lang=en_us&edition=fundamental","pubTime":"2025-03-06 07:43","pubTimestamp":1741218211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO0WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06855","BK1574"],"gpt_icon":0},{"id":"2517978453","title":"BRIEF-Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517978453","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517978453?lang=en_us&edition=fundamental","pubTime":"2025-03-06 07:03","pubTimestamp":1741215813,"startTime":"0","endTime":"0","summary":"BRIEF-Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)March 5 (Reuters) - Ascentage Pharma Group I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO16J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2517978965","title":"Olverembatinib Granted Breakthrough Therapy Designation for Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (All)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517978965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517978965?lang=en_us&edition=fundamental","pubTime":"2025-03-06 07:01","pubTimestamp":1741215701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO16J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06855","BK1161","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06855\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"06855","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"Post Market","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-22","symbol":"06855","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724290200000,"name":null,"time":"Post Market","dateTimestamp":1724256000000,"actualEps":null},{"date":"2024-03-27","symbol":"06855","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-21","symbol":"06855","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null},{"market":"HK","date":"2023-03-22","symbol":"06855","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1679414400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06855\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06855\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1743696000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06855\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06855","date":"2025-06-27","current":-59.787237,"percent":0.001625,"low":-61.253934,"twenty":-13.887677,"median":-7.076327,"eighty":-4.976297,"high":-3.289062,"avg":-11.675922,"sd":10.956855,"marketCap":26546208542},"quantilePoints":[{"date":"2020-07-03","current":-5.880702,"twenty":-42.431893,"median":-5.91627,"eighty":-3.602912,"marketCap":9550109583},{"date":"2020-07-10","current":-5.173084,"twenty":-42.226743,"median":-5.911001,"eighty":-3.61463,"marketCap":8481067465},{"date":"2020-07-17","current":-4.813065,"twenty":-42.12181,"median":-5.860228,"eighty":-3.623364,"marketCap":7903368580},{"date":"2020-07-24","current":-4.591381,"twenty":-42.042715,"median":-5.815681,"eighty":-3.628531,"marketCap":7509839854},{"date":"2020-07-31","current":-4.219087,"twenty":-41.997288,"median":-5.64528,"eighty":-3.647633,"marketCap":6941409472},{"date":"2020-08-07","current":-4.931344,"twenty":-41.91899,"median":-5.392,"eighty":-3.661326,"marketCap":8121995650},{"date":"2020-08-14","current":-4.866042,"twenty":-41.892481,"median":-5.309691,"eighty":-3.676844,"marketCap":8034544822},{"date":"2020-08-21","current":-6.073196,"twenty":-41.876573,"median":-5.335807,"eighty":-3.698825,"marketCap":7936162641},{"date":"2020-08-28","current":-5.644334,"twenty":-41.854797,"median":-5.447921,"eighty":-3.705249,"marketCap":7433320380},{"date":"2020-09-04","current":-5.352285,"twenty":-41.837297,"median":-5.496488,"eighty":-3.71908,"marketCap":7072585714},{"date":"2020-09-11","current":-4.743313,"twenty":-41.76226,"median":-5.423978,"eighty":-3.735901,"marketCap":6274596909},{"date":"2020-09-18","current":-5.311589,"twenty":-41.662381,"median":-5.331938,"eighty":-3.775137,"marketCap":7094448421},{"date":"2020-09-25","current":-4.438397,"twenty":-41.650445,"median":-5.309691,"eighty":-3.775789,"marketCap":5881068183},{"date":"2020-09-30","current":-4.671858,"twenty":-41.622609,"median":-5.179885,"eighty":-3.777294,"marketCap":6219940141},{"date":"2020-10-09","current":-4.815997,"twenty":-41.609135,"median":-5.087707,"eighty":-3.779424,"marketCap":6504155332},{"date":"2020-10-16","current":-4.615537,"twenty":-41.400702,"median":-5.033657,"eighty":-3.785911,"marketCap":6230871495},{"date":"2020-10-23","current":-4.430526,"twenty":-41.329371,"median":-4.993839,"eighty":-3.825673,"marketCap":5990381718},{"date":"2020-10-30","current":-4.397507,"twenty":-41.281698,"median":-4.975286,"eighty":-3.848798,"marketCap":5946656304},{"date":"2020-11-06","current":-4.522469,"twenty":-41.249119,"median":-4.912688,"eighty":-3.879703,"marketCap":6187146081},{"date":"2020-11-13","current":-4.247234,"twenty":-41.136,"median":-4.884963,"eighty":-3.899468,"marketCap":5815480062},{"date":"2020-11-20","current":-4.125559,"twenty":-41.039168,"median":-4.871375,"eighty":-3.921515,"marketCap":5684303820},{"date":"2020-11-27","current":-3.983415,"twenty":-41.003833,"median":-4.853211,"eighty":-3.938793,"marketCap":5475626750},{"date":"2020-12-04","current":-4.858991,"twenty":-40.948743,"median":-4.855563,"eighty":-3.943666,"marketCap":6727256658},{"date":"2020-12-11","current":-4.560767,"twenty":-40.913307,"median":-4.846229,"eighty":-3.945081,"marketCap":6299258273},{"date":"2020-12-18","current":-5.410119,"twenty":-40.86465,"median":-4.848988,"eighty":-3.968172,"marketCap":7484484569},{"date":"2020-12-24","current":-5.103412,"twenty":-40.64427,"median":-4.855563,"eighty":-3.993185,"marketCap":7067460502},{"date":"2020-12-31","current":-6.135006,"twenty":-40.34914,"median":-4.862516,"eighty":-4.014112,"marketCap":8499544284},{"date":"2021-01-08","current":-5.795977,"twenty":-5.970562,"median":-5.808629,"eighty":-5.699574,"marketCap":8102162992},{"date":"2021-01-15","current":-6.800577,"twenty":-6.71844,"median":-5.997969,"eighty":-5.757549,"marketCap":9492997512},{"date":"2021-01-22","current":-7.547072,"twenty":-7.072704,"median":-6.276354,"eighty":-5.803568,"marketCap":10530604216},{"date":"2021-01-29","current":-6.520118,"twenty":-7.15763,"median":-6.73213,"eighty":-5.827105,"marketCap":9172884805},{"date":"2021-02-05","current":-6.888402,"twenty":-7.324603,"median":-6.888402,"eighty":-5.852329,"marketCap":9632961066},{"date":"2021-02-11","current":-6.926566,"twenty":-7.264914,"median":-6.808604,"eighty":-5.944929,"marketCap":9700217458},{"date":"2021-02-19","current":-7.744834,"twenty":-7.412485,"median":-6.926566,"eighty":-6.08374,"marketCap":10850881008},{"date":"2021-02-26","current":-6.044895,"twenty":-7.348807,"median":-6.80459,"eighty":-6.08374,"marketCap":8450572097},{"date":"2021-03-05","current":-6.210924,"twenty":-7.282657,"median":-6.663683,"eighty":-6.137592,"marketCap":8660908445},{"date":"2021-03-12","current":-5.955167,"twenty":-7.193668,"median":-6.531192,"eighty":-5.955126,"marketCap":8289726654},{"date":"2021-03-19","current":-5.75265,"twenty":-7.118666,"median":-6.438084,"eighty":-5.928458,"marketCap":8005153948},{"date":"2021-03-26","current":-5.626337,"twenty":-7.105323,"median":-6.317122,"eighty":-5.811124,"marketCap":7794817600},{"date":"2021-04-01","current":-10.251604,"twenty":-7.121592,"median":-6.317122,"eighty":-5.795977,"marketCap":8228032232},{"date":"2021-04-09","current":-9.936769,"twenty":-7.324603,"median":-6.359882,"eighty":-5.803568,"marketCap":7992945596},{"date":"2021-04-16","current":-9.546836,"twenty":-7.533063,"median":-6.481914,"eighty":-5.816115,"marketCap":7708367038},{"date":"2021-04-23","current":-11.739429,"twenty":-7.988,"median":-6.615664,"eighty":-5.832096,"marketCap":9502449254},{"date":"2021-04-30","current":-11.571334,"twenty":-9.503281,"median":-6.746846,"eighty":-5.852329,"marketCap":9404994300},{"date":"2021-05-07","current":-11.814517,"twenty":-9.704075,"median":-6.888402,"eighty":-5.897449,"marketCap":9664869142},{"date":"2021-05-14","current":-13.623549,"twenty":-10.062703,"median":-6.991043,"eighty":-5.941787,"marketCap":11137493250},{"date":"2021-05-21","current":-14.527782,"twenty":-11.500106,"median":-7.053022,"eighty":-5.955136,"marketCap":11879992800},{"date":"2021-05-28","current":-14.116292,"twenty":-11.745952,"median":-7.106961,"eighty":-5.971077,"marketCap":11657242935},{"date":"2021-06-04","current":-14.098949,"twenty":-12.112667,"median":-7.256043,"eighty":-6.013448,"marketCap":11587725208},{"date":"2021-06-11","current":-13.40703,"twenty":-12.748945,"median":-7.425379,"eighty":-6.042682,"marketCap":11018242987},{"date":"2021-06-18","current":-13.000278,"twenty":-12.971694,"median":-7.523724,"eighty":-6.050101,"marketCap":10597321344},{"date":"2021-06-25","current":-14.953656,"twenty":-13.262296,"median":-7.654519,"eighty":-6.08374,"marketCap":12181967527},{"date":"2021-07-02","current":-13.821759,"twenty":-13.402928,"median":-8.048791,"eighty":-6.135006,"marketCap":11240194319},{"date":"2021-07-09","current":-13.744097,"twenty":-13.493257,"median":-9.34129,"eighty":-6.147934,"marketCap":11165838017},{"date":"2021-07-16","current":-14.613891,"twenty":-13.744097,"median":-9.537674,"eighty":-6.15536,"marketCap":11872222886},{"date":"2021-07-23","current":-16.484113,"twenty":-13.912728,"median":-9.687583,"eighty":-6.203213,"marketCap":13390290264},{"date":"2021-07-30","current":-14.391097,"twenty":-14.116292,"median":-9.813727,"eighty":-6.210924,"marketCap":11729379260},{"date":"2021-08-06","current":-13.903368,"twenty":-14.116292,"median":-10.251604,"eighty":-6.221841,"marketCap":11304495049},{"date":"2021-08-13","current":-13.188648,"twenty":-14.116292,"median":-11.496306,"eighty":-6.250869,"marketCap":10737982769},{"date":"2021-08-20","current":-11.65612,"twenty":-14.106588,"median":-11.655573,"eighty":-6.276354,"marketCap":9463330138},{"date":"2021-08-27","current":-11.061008,"twenty":-14.098949,"median":-11.543321,"eighty":-6.357891,"marketCap":9785212116},{"date":"2021-09-03","current":-11.428472,"twenty":-14.067954,"median":-11.428472,"eighty":-6.359882,"marketCap":10114400268},{"date":"2021-09-10","current":-10.962963,"twenty":-13.971316,"median":-11.404475,"eighty":-6.438084,"marketCap":9727369645},{"date":"2021-09-17","current":-10.645494,"twenty":-13.928089,"median":-11.29753,"eighty":-6.443709,"marketCap":9417745147},{"date":"2021-09-24","current":-10.188711,"twenty":-13.9158,"median":-11.109944,"eighty":-6.504836,"marketCap":9017813504},{"date":"2021-09-30","current":-10.049253,"twenty":-13.907112,"median":-11.061008,"eighty":-6.533407,"marketCap":8924147806},{"date":"2021-10-08","current":-9.526138,"twenty":-13.895112,"median":-10.995259,"eighty":-6.586305,"marketCap":8459213912},{"date":"2021-10-15","current":-9.129654,"twenty":-13.885746,"median":-10.944573,"eighty":-6.634872,"marketCap":8112697078},{"date":"2021-10-22","current":-9.093442,"twenty":-13.871977,"median":-10.653613,"eighty":-6.675456,"marketCap":8138533693},{"date":"2021-10-29","current":-8.378023,"twenty":-13.844711,"median":-10.604938,"eighty":-6.7361,"marketCap":7479700013},{"date":"2021-11-05","current":-7.807614,"twenty":-13.790694,"median":-10.288303,"eighty":-6.803788,"marketCap":6981938991},{"date":"2021-11-12","current":-9.345336,"twenty":-13.696298,"median":-10.182654,"eighty":-6.840523,"marketCap":8391497668},{"date":"2021-11-19","current":-10.065158,"twenty":-13.62418,"median":-10.049253,"eighty":-6.903668,"marketCap":9025062207},{"date":"2021-11-26","current":-9.456492,"twenty":-13.621799,"median":-10.099714,"eighty":-6.932286,"marketCap":8482006888},{"date":"2021-12-03","current":-8.665457,"twenty":-13.59895,"median":-10.045968,"eighty":-6.981007,"marketCap":7786858200},{"date":"2021-12-10","current":-8.069214,"twenty":-13.54512,"median":-9.952047,"eighty":-7.04502,"marketCap":7263449127},{"date":"2021-12-17","current":-7.401896,"twenty":-13.503232,"median":-9.77926,"eighty":-7.052562,"marketCap":6658161700},{"date":"2021-12-24","current":-7.55217,"twenty":-13.464483,"median":-9.765737,"eighty":-7.067852,"marketCap":6799824715},{"date":"2021-12-31","current":-8.050733,"twenty":-13.421058,"median":-9.745268,"eighty":-7.089068,"marketCap":7264487959},{"date":"2022-01-07","current":-7.279006,"twenty":-7.75305,"median":-7.526873,"eighty":-7.289142,"marketCap":6543191282},{"date":"2022-01-14","current":-7.735009,"twenty":-7.922162,"median":-7.660411,"eighty":-7.418388,"marketCap":6968241109},{"date":"2022-01-21","current":-7.332187,"twenty":-7.818789,"median":-7.595368,"eighty":-7.432903,"marketCap":6620473069},{"date":"2022-01-28","current":-5.508922,"twenty":-7.758783,"median":-7.545802,"eighty":-7.257505,"marketCap":4961490712},{"date":"2022-02-04","current":-5.823625,"twenty":-7.735009,"median":-7.527812,"eighty":-6.8626,"marketCap":5242350394},{"date":"2022-02-11","current":-5.591977,"twenty":-7.725454,"median":-7.332187,"eighty":-6.005508,"marketCap":5043991190},{"date":"2022-02-18","current":-5.649907,"twenty":-7.705412,"median":-7.287453,"eighty":-5.823625,"marketCap":5121273997},{"date":"2022-02-25","current":-5.290141,"twenty":-7.681118,"median":-6.8626,"eighty":-5.649907,"marketCap":4806990582},{"date":"2022-03-04","current":-4.658984,"twenty":-7.595368,"median":-6.098551,"eighty":-5.395841,"marketCap":4235099456},{"date":"2022-03-11","current":-4.149473,"twenty":-7.563931,"median":-5.952538,"eighty":-5.212357,"marketCap":3766250246},{"date":"2022-03-18","current":-4.439644,"twenty":-7.562853,"median":-5.839136,"eighty":-5.044022,"marketCap":4013555324},{"date":"2022-03-25","current":-4.422658,"twenty":-7.528752,"median":-5.779683,"eighty":-4.516027,"marketCap":4255708213},{"date":"2022-04-01","current":-4.289929,"twenty":-7.526873,"median":-5.620942,"eighty":-4.439644,"marketCap":4132900853},{"date":"2022-04-08","current":-4.181137,"twenty":-7.505412,"median":-5.544631,"eighty":-4.420356,"marketCap":4029835994},{"date":"2022-04-14","current":-4.000619,"twenty":-7.399331,"median":-5.342991,"eighty":-4.291314,"marketCap":3849472491},{"date":"2022-04-22","current":-3.73845,"twenty":-7.322784,"median":-5.23361,"eighty":-4.257411,"marketCap":3529971427},{"date":"2022-04-29","current":-3.749681,"twenty":-7.303568,"median":-5.172273,"eighty":-4.126477,"marketCap":3483592240},{"date":"2022-05-06","current":-3.289062,"twenty":-7.29252,"median":-5.056256,"eighty":-3.977012,"marketCap":3030276980},{"date":"2022-05-13","current":-3.354678,"twenty":-7.279006,"median":-4.882615,"eighty":-3.853853,"marketCap":3035430512},{"date":"2022-05-20","current":-4.381058,"twenty":-7.225253,"median":-4.659306,"eighty":-3.762541,"marketCap":4019755178},{"date":"2022-05-27","current":-4.244322,"twenty":-6.8626,"median":-4.568101,"eighty":-3.802686,"marketCap":3890916871},{"date":"2022-06-02","current":-4.945634,"twenty":-6.380165,"median":-4.636629,"eighty":-3.84362,"marketCap":4558167430},{"date":"2022-06-10","current":-4.905803,"twenty":-6.140574,"median":-4.665254,"eighty":-3.919676,"marketCap":4491059642},{"date":"2022-06-17","current":-5.22731,"twenty":-6.091184,"median":-4.785423,"eighty":-3.941746,"marketCap":4780139343},{"date":"2022-06-24","current":-6.030299,"twenty":-6.041494,"median":-4.844773,"eighty":-3.951055,"marketCap":5536392490},{"date":"2022-06-30","current":-6.005239,"twenty":-6.037992,"median":-4.87479,"eighty":-3.963878,"marketCap":5503892565},{"date":"2022-07-08","current":-5.497733,"twenty":-6.050195,"median":-4.886129,"eighty":-3.988815,"marketCap":5043942858},{"date":"2022-07-15","current":-4.883944,"twenty":-6.037992,"median":-4.920541,"eighty":-4.005342,"marketCap":4439289872},{"date":"2022-07-22","current":-4.630739,"twenty":-6.023868,"median":-4.893709,"eighty":-4.016862,"marketCap":4211899005},{"date":"2022-07-29","current":-4.545648,"twenty":-6.011137,"median":-4.884775,"eighty":-4.071152,"marketCap":4139547366},{"date":"2022-08-05","current":-4.75744,"twenty":-6.005347,"median":-4.875811,"eighty":-4.108138,"marketCap":4321383484},{"date":"2022-08-12","current":-4.546379,"twenty":-5.973618,"median":-4.844773,"eighty":-4.131261,"marketCap":4135295200},{"date":"2022-08-19","current":-4.557903,"twenty":-5.912795,"median":-4.80101,"eighty":-4.147552,"marketCap":4104280486},{"date":"2022-08-26","current":-4.591546,"twenty":-5.872374,"median":-4.771461,"eighty":-4.153531,"marketCap":4259354056},{"date":"2022-09-02","current":-4.315555,"twenty":-5.858025,"median":-4.75744,"eighty":-4.171177,"marketCap":3988956392},{"date":"2022-09-09","current":-4.568033,"twenty":-5.836034,"median":-4.696556,"eighty":-4.18363,"marketCap":4206253628},{"date":"2022-09-16","current":-4.202315,"twenty":-5.809818,"median":-4.674609,"eighty":-4.192101,"marketCap":3833744081},{"date":"2022-09-23","current":-3.75839,"twenty":-5.785681,"median":-4.659628,"eighty":-4.146592,"marketCap":3362933405},{"date":"2022-09-30","current":-3.420047,"twenty":-5.780199,"median":-4.633684,"eighty":-4.030431,"marketCap":3066036399},{"date":"2022-10-07","current":-3.304695,"twenty":-5.772985,"median":-4.598055,"eighty":-3.983075,"marketCap":2962454088},{"date":"2022-10-14","current":-3.818951,"twenty":-5.732612,"median":-4.578178,"eighty":-3.937536,"marketCap":3387141563},{"date":"2022-10-21","current":-4.598919,"twenty":-5.677029,"median":-4.570576,"eighty":-3.937536,"marketCap":4050984835},{"date":"2022-10-28","current":-4.547461,"twenty":-5.667607,"median":-4.568101,"eighty":-3.945126,"marketCap":3998798398},{"date":"2022-11-04","current":-5.32651,"twenty":-5.644885,"median":-4.575615,"eighty":-3.956647,"marketCap":4729430356},{"date":"2022-11-11","current":-5.15869,"twenty":-5.618231,"median":-4.594808,"eighty":-3.972626,"marketCap":4621240773},{"date":"2022-11-18","current":-5.355318,"twenty":-5.589649,"median":-4.604285,"eighty":-3.983075,"marketCap":4780949205},{"date":"2022-11-25","current":-4.874618,"twenty":-5.578642,"median":-4.630739,"eighty":-4.002193,"marketCap":4317279562},{"date":"2022-12-02","current":-6.015095,"twenty":-5.644885,"median":-4.65636,"eighty":-4.011281,"marketCap":5419304646},{"date":"2022-12-09","current":-7.236825,"twenty":-5.772985,"median":-4.660091,"eighty":-4.026437,"marketCap":6580584213},{"date":"2022-12-16","current":-7.267967,"twenty":-5.848443,"median":-4.674609,"eighty":-4.054655,"marketCap":6593487319},{"date":"2022-12-23","current":-7.1093,"twenty":-5.977886,"median":-4.706461,"eighty":-4.105129,"marketCap":6451553150},{"date":"2022-12-30","current":-7.220636,"twenty":-6.007425,"median":-4.725571,"eighty":-4.109643,"marketCap":6632196638},{"date":"2023-01-06","current":-7.694101,"twenty":-6.037992,"median":-4.762252,"eighty":-4.131261,"marketCap":7139680501},{"date":"2023-01-13","current":-8.0685,"twenty":-6.137143,"median":-4.785423,"eighty":-4.147552,"marketCap":7630291458},{"date":"2023-01-20","current":-6.707993,"twenty":-6.236164,"median":-4.821923,"eighty":-4.153531,"marketCap":6289239238},{"date":"2023-01-27","current":-6.871876,"twenty":-6.259556,"median":-4.844773,"eighty":-4.156237,"marketCap":6444210226},{"date":"2023-02-03","current":-9.532458,"twenty":-6.671653,"median":-4.856252,"eighty":-4.169881,"marketCap":8985503328},{"date":"2023-02-10","current":-8.391323,"twenty":-6.81059,"median":-4.875215,"eighty":-4.181137,"marketCap":7862315412},{"date":"2023-02-17","current":-7.820965,"twenty":-6.871876,"median":-4.882615,"eighty":-4.185292,"marketCap":7258601907},{"date":"2023-02-24","current":-7.42769,"twenty":-7.1093,"median":-4.885868,"eighty":-4.202315,"marketCap":6809326740},{"date":"2023-03-03","current":-7.988771,"twenty":-7.236825,"median":-4.905803,"eighty":-4.244322,"marketCap":7370920698},{"date":"2023-03-10","current":-6.714477,"twenty":-7.150334,"median":-6.975085,"eighty":-6.81872,"marketCap":6149453840},{"date":"2023-03-17","current":-7.029708,"twenty":-13.169241,"median":-6.203213,"eighty":-4.468986,"marketCap":6500450063},{"date":"2023-03-24","current":-6.865025,"twenty":-13.12443,"median":-6.214512,"eighty":-4.471141,"marketCap":6977804928},{"date":"2023-03-31","current":-6.221904,"twenty":-13.040957,"median":-6.221904,"eighty":-4.48105,"marketCap":6275812480},{"date":"2023-04-06","current":-6.518412,"twenty":-12.971694,"median":-6.22549,"eighty":-4.487435,"marketCap":6570649308},{"date":"2023-04-14","current":-7.2358,"twenty":-12.857356,"median":-6.248416,"eighty":-4.488207,"marketCap":7300986654},{"date":"2023-04-21","current":-6.571259,"twenty":-12.623507,"median":-6.259556,"eighty":-4.495947,"marketCap":6627049424},{"date":"2023-04-28","current":-6.424183,"twenty":-12.586329,"median":-6.302365,"eighty":-4.497582,"marketCap":6430484399},{"date":"2023-05-05","current":-6.161601,"twenty":-12.577189,"median":-6.259685,"eighty":-4.499348,"marketCap":6177757938},{"date":"2023-05-12","current":-5.915737,"twenty":-12.552065,"median":-6.250035,"eighty":-4.504844,"marketCap":5890406037},{"date":"2023-05-19","current":-5.548301,"twenty":-12.470798,"median":-6.226231,"eighty":-4.506603,"marketCap":5446859875},{"date":"2023-05-25","current":-5.808178,"twenty":-12.397891,"median":-6.221872,"eighty":-4.509525,"marketCap":5678520927},{"date":"2023-06-02","current":-6.117886,"twenty":-12.326841,"median":-6.210924,"eighty":-4.512316,"marketCap":5961034406},{"date":"2023-06-09","current":-5.970883,"twenty":-12.277549,"median":-6.202755,"eighty":-4.514789,"marketCap":5809406293},{"date":"2023-06-16","current":-6.481337,"twenty":-12.243849,"median":-6.202297,"eighty":-4.516428,"marketCap":6275854974},{"date":"2023-06-23","current":-5.477704,"twenty":-12.175688,"median":-6.202297,"eighty":-4.519005,"marketCap":5275110532},{"date":"2023-06-30","current":-6.250514,"twenty":-12.088451,"median":-6.179971,"eighty":-4.52547,"marketCap":5964889187},{"date":"2023-07-07","current":-6.707949,"twenty":-12.024727,"median":-6.203213,"eighty":-4.531593,"marketCap":6388933442},{"date":"2023-07-14","current":-6.547449,"twenty":-11.918622,"median":-6.21284,"eighty":-4.538228,"marketCap":6323573156},{"date":"2023-07-21","current":-6.636884,"twenty":-11.879422,"median":-6.221841,"eighty":-4.544768,"marketCap":6380159941},{"date":"2023-07-28","current":-6.923899,"twenty":-11.836651,"median":-6.226231,"eighty":-4.545333,"marketCap":6648947167},{"date":"2023-08-04","current":-6.626098,"twenty":-11.788831,"median":-6.250035,"eighty":-4.54594,"marketCap":6373549728},{"date":"2023-08-11","current":-8.226201,"twenty":-11.745952,"median":-6.255212,"eighty":-4.546812,"marketCap":7867988828},{"date":"2023-08-18","current":-7.296654,"twenty":-11.706105,"median":-6.276354,"eighty":-4.551638,"marketCap":6928952187},{"date":"2023-08-25","current":-7.299339,"twenty":-11.655901,"median":-6.352148,"eighty":-4.559049,"marketCap":6900496531},{"date":"2023-09-01","current":-7.23946,"twenty":-11.621877,"median":-6.359882,"eighty":-4.563254,"marketCap":6872305463},{"date":"2023-09-08","current":-6.840355,"twenty":-11.548924,"median":-6.378594,"eighty":-4.567204,"marketCap":6416997440},{"date":"2023-09-15","current":-6.667323,"twenty":-11.500106,"median":-6.416146,"eighty":-4.567733,"marketCap":6303170435},{"date":"2023-09-22","current":-6.560554,"twenty":-11.457771,"median":-6.420165,"eighty":-4.56806,"marketCap":6175115053},{"date":"2023-09-29","current":-6.307872,"twenty":-11.409274,"median":-6.424183,"eighty":-4.570081,"marketCap":5947461042},{"date":"2023-10-06","current":-6.144917,"twenty":-11.367811,"median":-6.401243,"eighty":-4.57318,"marketCap":5791042519},{"date":"2023-10-13","current":-6.789178,"twenty":-11.31322,"median":-6.419502,"eighty":-4.574588,"marketCap":6388643959},{"date":"2023-10-20","current":-6.572494,"twenty":-11.288844,"median":-6.438084,"eighty":-4.579422,"marketCap":6175214873},{"date":"2023-10-27","current":-7.181335,"twenty":-11.254098,"median":-6.452236,"eighty":-4.584398,"marketCap":6744359101},{"date":"2023-11-03","current":-7.874935,"twenty":-11.109944,"median":-6.481204,"eighty":-4.591381,"marketCap":7415390968},{"date":"2023-11-10","current":-7.800989,"twenty":-11.095483,"median":-6.500289,"eighty":-4.591546,"marketCap":7344225987},{"date":"2023-11-17","current":-7.87417,"twenty":-11.061008,"median":-6.519265,"eighty":-4.593656,"marketCap":7479980948},{"date":"2023-11-24","current":-7.275359,"twenty":-11.052445,"median":-6.542267,"eighty":-4.594808,"marketCap":6968043089},{"date":"2023-12-01","current":-7.455114,"twenty":-11.010318,"median":-6.5498,"eighty":-4.598919,"marketCap":7169812549},{"date":"2023-12-08","current":-7.11407,"twenty":-10.9802,"median":-6.560554,"eighty":-4.601303,"marketCap":6814167085},{"date":"2023-12-15","current":-7.811558,"twenty":-10.962963,"median":-6.570665,"eighty":-4.606616,"marketCap":7525458012},{"date":"2023-12-22","current":-7.506472,"twenty":-10.926183,"median":-6.573376,"eighty":-4.607268,"marketCap":7226715823},{"date":"2023-12-29","current":-8.02519,"twenty":-10.864263,"median":-6.590434,"eighty":-4.608718,"marketCap":7767296928},{"date":"2024-01-05","current":-7.834828,"twenty":-10.755235,"median":-6.596434,"eighty":-4.612026,"marketCap":7529571834},{"date":"2024-01-12","current":-7.963884,"twenty":-10.650365,"median":-6.602943,"eighty":-4.621618,"marketCap":7657674190},{"date":"2024-01-19","current":-6.818635,"twenty":-10.636772,"median":-6.611977,"eighty":-4.633095,"marketCap":6547453769},{"date":"2024-01-26","current":-7.172658,"twenty":-10.609875,"median":-6.626098,"eighty":-4.643472,"marketCap":6860592862},{"date":"2024-02-02","current":-6.390216,"twenty":-10.587967,"median":-6.636109,"eighty":-4.655835,"marketCap":6104399794},{"date":"2024-02-09","current":-6.492303,"twenty":-10.552583,"median":-6.636884,"eighty":-4.659242,"marketCap":6232464125},{"date":"2024-02-16","current":-7.365245,"twenty":-10.502176,"median":-6.645968,"eighty":-4.659628,"marketCap":7071996964},{"date":"2024-02-23","current":-7.597951,"twenty":-10.288303,"median":-6.663683,"eighty":-4.660091,"marketCap":7256978776},{"date":"2024-03-01","current":-7.533661,"twenty":-10.251604,"median":-6.670184,"eighty":-4.667351,"marketCap":7200061295},{"date":"2024-03-08","current":-7.113615,"twenty":-10.223332,"median":-6.681591,"eighty":-4.668256,"marketCap":6801638931},{"date":"2024-03-15","current":-7.179498,"twenty":-10.188711,"median":-6.689188,"eighty":-4.670881,"marketCap":6858556412},{"date":"2024-03-22","current":-6.455537,"twenty":-10.176596,"median":-6.68526,"eighty":-4.671858,"marketCap":6161317274},{"date":"2024-03-28","current":-5.042316,"twenty":-10.147982,"median":-6.681591,"eighty":-4.677042,"marketCap":5054272277},{"date":"2024-04-05","current":-4.68767,"twenty":-10.138205,"median":-6.674129,"eighty":-4.679785,"marketCap":4695692149},{"date":"2024-04-12","current":-5.059812,"twenty":-10.106625,"median":-6.667323,"eighty":-4.683834,"marketCap":5071347521},{"date":"2024-04-19","current":-4.461667,"twenty":-10.058796,"median":-6.65453,"eighty":-4.683834,"marketCap":4468022227},{"date":"2024-04-26","current":-5.01348,"twenty":-10.047939,"median":-6.636884,"eighty":-4.687059,"marketCap":5014430040},{"date":"2024-05-03","current":-5.239037,"twenty":-10.032312,"median":-6.626098,"eighty":-4.68821,"marketCap":5236408215},{"date":"2024-05-10","current":-5.709524,"twenty":-9.975616,"median":-6.611977,"eighty":-4.690926,"marketCap":5720206800},{"date":"2024-05-17","current":-5.846166,"twenty":-9.967326,"median":-6.605183,"eighty":-4.693145,"marketCap":5848507456},{"date":"2024-05-24","current":-5.19518,"twenty":-9.936769,"median":-6.601468,"eighty":-4.699429,"marketCap":5185392012},{"date":"2024-05-31","current":-5.070263,"twenty":-9.85731,"median":-6.592585,"eighty":-4.706461,"marketCap":5065860473},{"date":"2024-06-07","current":-5.932158,"twenty":-9.850109,"median":-6.573376,"eighty":-4.709348,"marketCap":5919657182},{"date":"2024-06-14","current":-6.580183,"twenty":-9.810769,"median":-6.572935,"eighty":-4.710708,"marketCap":6560299615},{"date":"2024-06-21","current":-7.096802,"twenty":-9.781373,"median":-6.588766,"eighty":-4.714838,"marketCap":7060545888},{"date":"2024-06-28","current":-7.939528,"twenty":-9.773791,"median":-6.596434,"eighty":-4.717661,"marketCap":7895689621},{"date":"2024-07-05","current":-8.423012,"twenty":-9.7694,"median":-6.602017,"eighty":-4.719383,"marketCap":8374684490},{"date":"2024-07-12","current":-8.627929,"twenty":-9.766246,"median":-6.607424,"eighty":-4.726438,"marketCap":8591026994},{"date":"2024-07-19","current":-8.782943,"twenty":-9.762604,"median":-6.620471,"eighty":-4.734193,"marketCap":8745541868},{"date":"2024-07-26","current":-8.348471,"twenty":-9.74856,"median":-6.635334,"eighty":-4.734343,"marketCap":8343803196},{"date":"2024-08-02","current":-8.492561,"twenty":-9.712321,"median":-6.645968,"eighty":-4.735775,"marketCap":8482866582},{"date":"2024-08-09","current":-8.789769,"twenty":-9.686952,"median":-6.663683,"eighty":-4.739953,"marketCap":8838250792},{"date":"2024-08-16","current":-8.789494,"twenty":-9.67409,"median":-6.670184,"eighty":-4.743547,"marketCap":8841408776},{"date":"2024-08-23","current":-22.565375,"twenty":-9.67409,"median":-6.681591,"eighty":-4.747946,"marketCap":8872322792},{"date":"2024-08-30","current":-25.890373,"twenty":-9.762604,"median":-6.689188,"eighty":-4.755386,"marketCap":10247996536},{"date":"2024-09-06","current":-25.565659,"twenty":-9.78243,"median":-6.698449,"eighty":-4.759089,"marketCap":10124340469},{"date":"2024-09-13","current":-26.180633,"twenty":-9.955103,"median":-6.707971,"eighty":-4.763763,"marketCap":10340738586},{"date":"2024-09-20","current":-30.186941,"twenty":-10.048596,"median":-6.717242,"eighty":-4.768074,"marketCap":11994638479},{"date":"2024-09-27","current":-31.100467,"twenty":-10.169443,"median":-6.722397,"eighty":-4.772655,"marketCap":12431943746},{"date":"2024-10-04","current":-32.833844,"twenty":-10.251604,"median":-6.72658,"eighty":-4.774812,"marketCap":13065218410},{"date":"2024-10-10","current":-32.96952,"twenty":-10.58678,"median":-6.72951,"eighty":-4.775649,"marketCap":13034258177},{"date":"2024-10-18","current":-37.550812,"twenty":-10.687487,"median":-6.742281,"eighty":-4.777084,"marketCap":14768031236},{"date":"2024-10-25","current":-36.996518,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":14549115445},{"date":"2024-11-01","current":-34.766687,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13681436568},{"date":"2024-11-08","current":-34.885561,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13665942303},{"date":"2024-11-15","current":-33.979692,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13170125802},{"date":"2024-11-22","current":-32.715953,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":12674309301},{"date":"2024-11-29","current":-34.538895,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13371551255},{"date":"2024-12-06","current":-32.734971,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":12643320770},{"date":"2024-12-13","current":-31.082818,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":11994263871},{"date":"2024-12-20","current":-34.686724,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13311463392},{"date":"2024-12-27","current":-36.006829,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13807350270},{"date":"2025-01-03","current":-35.325656,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":13559406831},{"date":"2025-01-10","current":-32.177431,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":12304193170},{"date":"2025-01-17","current":-32.070499,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":12273200240},{"date":"2025-01-24","current":-29.617306,"twenty":-10.969858,"median":-6.757513,"eighty":-4.779758,"marketCap":11405398203},{"date":"2025-01-28","current":-29.766501,"twenty":-10.986224,"median":-6.766077,"eighty":-4.780547,"marketCap":11517583264},{"date":"2025-02-07","current":-32.664532,"twenty":-10.948251,"median":-6.74895,"eighty":-4.778969,"marketCap":12573240010},{"date":"2025-02-14","current":-31.242386,"twenty":-10.948251,"median":-6.74895,"eighty":-4.778969,"marketCap":11997107719},{"date":"2025-02-21","current":-36.382297,"twenty":-10.948251,"median":-6.74895,"eighty":-4.778969,"marketCap":14047460874},{"date":"2025-02-28","current":-33.43308,"twenty":-10.948251,"median":-6.74895,"eighty":-4.778969,"marketCap":12866204246},{"date":"2025-03-07","current":-34.452224,"twenty":-10.905543,"median":-6.746166,"eighty":-4.77818,"marketCap":13311638747},{"date":"2025-03-14","current":-33.065652,"twenty":-10.905543,"median":-6.746166,"eighty":-4.77818,"marketCap":12780543765},{"date":"2025-03-21","current":-32.72391,"twenty":-10.905543,"median":-6.746166,"eighty":-4.77818,"marketCap":12643486995},{"date":"2025-03-28","current":-33.955809,"twenty":-10.905543,"median":-6.746166,"eighty":-4.77818,"marketCap":14733602732},{"date":"2025-04-03","current":-35.838555,"twenty":-11.04402,"median":-6.79287,"eighty":-4.792288,"marketCap":15555943349},{"date":"2025-04-11","current":-29.511221,"twenty":-11.288844,"median":-6.811165,"eighty":-4.814633,"marketCap":12694883284},{"date":"2025-04-17","current":-29.551715,"twenty":-11.457771,"median":-6.818635,"eighty":-4.83159,"marketCap":12729147476},{"date":"2025-04-25","current":-41.553435,"twenty":-11.65612,"median":-6.851322,"eighty":-4.85134,"marketCap":17933455711},{"date":"2025-05-02","current":-38.492689,"twenty":-11.844029,"median":-6.870226,"eighty":-4.853819,"marketCap":16647822302},{"date":"2025-05-09","current":-37.35919,"twenty":-12.089857,"median":-6.908245,"eighty":-4.867696,"marketCap":16271019740},{"date":"2025-05-16","current":-35.007117,"twenty":-12.451909,"median":-6.932121,"eighty":-4.875811,"marketCap":15371186021},{"date":"2025-05-23","current":-39.338512,"twenty":-12.857356,"median":-6.947827,"eighty":-4.883944,"marketCap":17324714679},{"date":"2025-05-30","current":-38.856398,"twenty":-13.188648,"median":-6.975085,"eighty":-4.893966,"marketCap":17187624948},{"date":"2025-06-06","current":-42.814884,"twenty":-13.353771,"median":-7.024524,"eighty":-4.920616,"marketCap":18986927660},{"date":"2025-06-13","current":-48.171029,"twenty":-13.493257,"median":-7.041221,"eighty":-4.970261,"marketCap":21370640446},{"date":"2025-06-20","current":-55.929302,"twenty":-13.6246,"median":-7.0565,"eighty":-4.975286,"marketCap":24763893701},{"date":"2025-06-27","current":-59.787237,"twenty":-13.887677,"median":-7.076327,"eighty":-4.976297,"marketCap":26546208542}],"updateTime":1751088853055}}}